Brexit: Regulatory Impact

Introduction On 29 March 2017, the United Kingdom notified the European Council of its intention to withdraw from the European Union, a process known as “Brexit”. As a consequence of this, the European Medicines Agency (EMA) relocated from London to Amsterdam, and the United Kingdom will become a “third country” starting 30 March 2019.  …